Pilot Randomized Study of Early Tacrolimus Withdrawal from a Regimen with Sirolimus Plus Tacrolimus in Kidney Transplantation
Open Access
- 16 July 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (8) , 1308-1314
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2Transplantation, 2003
- Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine–based immunosuppressive regimen: incidence, risk factors, progression, and prognosis1Transplantation, 2003
- A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipientsTransplantation, 2003
- Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patientsTransplantation, 2003
- Improved freedom from rejection after a loading dose of sirolimusTransplantation, 2003
- Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantationKidney International, 2002
- Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine1Transplantation, 2002
- Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Cyclosporine A, Fk-506, And Rapamycin: Pharmacological Probes Of Lymphocyte Signal TransductionAnnual Review of Immunology, 1992
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990